血栓性血栓性紫:在2025年早期诊断和有效治疗
Elie Azoulay1,2, Agnès Veyradier3, Spero Cataland4
1Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris-Cité University, 1 Avenue Claude Vellefaux, Paris, France. elie.azoulay@aphp.fr.
Intensive care medicine
|July 3, 2025
概括
由于了解ADAMTS13缺陷的进步,血栓性血栓塞性紫外线 (TTP) 的生存率已提高到95%以上. 这篇评论是为了纪念TTP的诞生.
科学领域:
- 血液学 血液学 血液学
- 密集护理医学 密集护理医学
- 罕见疾病 罕见疾病
背景情况:
- 血栓性血栓细胞性紫外线 (TTP) 是一种罕见的,危及生命的血栓性微血管病变.
- 从历史上看,TTP几乎具有普遍的死亡率.
- 2024年是TTP最初描述的百年纪念日.
研究的目的:
- 总结一个世纪以来在TTP理解和管理方面的进步.
- 突出临床医生,科学家和工业界的主要贡献.
- 为欧洲重症监护医学学会的教育倡议提供全面的概述.
主要方法:
- 对TTP的历史和当前文献的审查.
- 巩固关于TTP病理生理学,诊断和治疗的知识.
- 专注于ADAMTS13缺陷及其影响的作用.
主要成果:
- 对TTP的生存率大幅提高至95%以上.
- 了解ADAMTS13缺乏症是TTP病理生理学 (免疫性TTP和先天性TTP) 的核心.
- 突破包括向疗法,如治疗性血交换,卡普拉齐祖马布和重组ADAMTS13.
结论:
- 100多年的合作努力已经改变了TTP的管理.
- 诊断和向治疗的进步显著改善了患者的治疗结果.
- 持续关注意识和最佳实践对于TTP护理的进一步进展至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
46
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
46
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
263
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
263
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
Peripheral Artery Disease III: Interprofessional Care
32
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32


